Caribou Biosciences, Inc. recently reported very exciting early data, with more in the allogeneic CAR T-cell pipeline. Read more on CRBU stock here.
Has BridgeBio's business model worked? How are executives at Moderna dealing with the company's slump? Find out on the new episode of "The Readout LOUD." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback